Physician Resources: 2025 ATA management guidelines for adult patients with differentiated thyroid cancer: updates from the endocrinology perspective

In this CME, William Doerfler, MD, discusses how to follow optimal approach for patients undergoing active surveillance, describe the initial risk of recurrence stratification, review changes in dynamic risk stratification and response to therapy, explain changes in TSH suppression guidance, and consider de-escalation or discontinuation of surveillance in patients with low-risk DTC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Follow optimal approach for patients undergoing active surveillance.
  • Describe the initial risk of recurrence stratification.
  • Review changes in dynamic risk stratification and response to therapy.
  • Explain changes in TSH suppression guidance.
  • Discuss de-escalation or discontinuation of surveillance in patients with low-risk DTC.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.75 Attendance
Course opens: 
01/09/2026
Course expires: 
01/09/2029
Physician Resources
United States

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.75 Attendance
Please login or register to take this course.